Palindromic Rheumatism: Biology and Treatment Options
Open Access
- 19 May 2021
- book chapter
- Published by IntechOpen
Abstract
Palindromic rheumatism is a syndrome characterized by recurrent, self-resolving, and inflammatory attacks in and around the joints that have long recognized association with rheumatoid arthritis. PR attacks mostly start in small joints i.e. knees, shoulder, and small joints of the hand. Whether PR should be considered as a single disease or prodrome of RA remains a thought-provoking question. Multiple genetic and environmental factors contribute to the development of PR. Many studies have explained the relationship between a high concentration of Anti-CCP antibodies and PR. Potential benefits of Gold therapy have been recognized in literature but still, there are some questions about toxicity and efficacy that need further considerations. In addition to that anti-malarial drugs, Abatacept, Tofacitinib, and Rituximab showed the variable result in different patients and needed further study to validate their medical use. Moreover, yarrow, oat, colchicum, dill, fennel, wild rue, bitter melon, willow, garlic, and burdock seem suitable candidates to treat rheumatoid although their use in PR is still not reported. Additional experimental researches on these drugs lead to an increase in our knowledge to fight against PR in the future using novel therapeutic approaches. We have attempted to cover this topic in a chapter form to provide a comprehensive view and hope that it will serve as a reference for clinicians who treat patients with PR.Keywords
This publication has 36 references indexed in Scilit:
- Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritisArthritis Research & Therapy, 2011
- Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?Annals of the Rheumatic Diseases, 2007
- Palindromic rheumatism: different genetic background implies a distinct disease entityAnnals of the Rheumatic Diseases, 2006
- A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullinationArthritis & Rheumatism, 2005
- Relationship between the tumor necrosis factor receptor II (TNF-RII) gene polymorphism and sTNF-RII plasma levels in healthy controls and in rheumatoid arthritisHuman Immunology, 2004
- Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritisArthritis & Rheumatism, 1990
- Palindromic rheumatism in Israel — a disease entity ? A survey of 34 patientsClinical Rheumatology, 1989
- The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritisArthritis & Rheumatism, 1987
- HLA ANTIGENS IN PALINDROMIC RHEUMATISM AND PALINDROMIC ONSET RHEUMATOID ARTHRITISRheumatology, 1986
- Palindromic rheumatism among allergic personsJournal of Allergy, 1943